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Introduction
Epithelial tumours comprise over 50% of human malignancies, and can express a range of viral and neo-self antigens. Immunotherapy directed at tumour specific antigens has been mooted as therapy for epithelial squamous cancer (Urosevic and Dummer, 2002) .
Successful immunotherapy induces a range of antigen specific immune responses including CD8 effector T cells which are widely held to be responsible for control of tumour growth in vivo. MHC class I restricted CD8 T cells induced by immunisation can induce regression of tumours expressing the E7 protein of human papillomavirus type 16 (HPV16-E7) (Chen et al., 1991) . However when HPV16-E7 is presented by epithelial cells in skin, such immunisation is insufficient to eradicate antigen expressing cells (Dunn et al., 1997) . Cell death induced by CD8 T cells is generally evaluated in short term in vitro lysis assays, that most effectively demonstrate rapid lytic mechanisms based on perforin (Trapani and Smyth, 2002) . In vivo, elimination of epithelial grafts, even from primed animals, occurs over several days or weeks. Thus, distinct effector mechanisms may be responsible for elimination of transplantable tumours versus elimination of antigen bearing skin.
Alternate mechanisms for CD8 T cell mediated induction of epithelial cell death are well recognised. These include cytolysis following Fas/Fas-L interactions (Daehn et al., 2006) which is generally deemed to require 6-8 hours, and TNF-a and TRAIL mediated differentiation and apoptosis (Basile et al., 2001) . IFN-γ has also been shown to kill transformed epithelial cell lines in vitro (Konur et al., 2005) . We therefore decided to examine the effects of various T cell effector mechanisms on the clonogenic potential of non-malignant keratinocytes and on the survival of skin expressing non-self antigen only in keratinocytes. This work distinguishes itself from most work on mechanism of skin allograft rejection in that non-self antigens are expressed only by epithelial cells, and 4 not by antigen presenting cells, vascular or stromal cells, and can therefore be cross presented but not directly presented by these cells.
Results

Requirements for rejection of skin grafts expressing antigen in keratinocytes
We first defined the role of MHC class I restricted T cells in destruction of epithelium expressing antigen in keratinocytes (KC). Skin from mice expressing a single MHC class I epitope of OVA (SIINFEKL) in KC from a keratin 14 promoter (K14-OVAp) was grafted onto mice expressing an irrelevant peptide, SIYRYYGL, as a transgene in the same expression cassette (K14-SIYp). Grafts from K14-OVAp animals were rejected at low frequency by untreated K14-SIYp animals (Fig 1 a) , whereas grafts from non-transgenic animals were not rejected (data not shown). Adoptive transfer of antigen specific spleen cells at the time of grafting increased the rate of graft rejection compared to untreated recipients although the increase did not reach statistical significance. To establish whether antigen in epithelial cells must necessarily be presented via MHC class I to enable effector function, skin from mice expressing membrane associated OVA protein from a keratin 5 promoter (K5-mOVA), and either expressing β2-microglobulin (b 2 m) or b 2 m deficient was grafted to naïve C57 recipients. K5-mOVA b 2 m +/+ grafts were rapidly rejected, whereas K5-mOVA b 2 m -/-grafts generally survived (Fig 1 b) . Thus, KC expressing full length OVA and potentially presenting a diversity of MHC class I and II epitopes, in contrast to KC expressing a minimal OVA CTL epitope, can mediate priming of MHC Class I restricted T cells. Taken together the data also show that antigen primed 6 MHC class I restricted T cells are necessary and sufficient to affect rejection of epithelium expressing antigen in KC.
Perforin and Fas-L are not required for T cell mediated inhibition of keratinocyte colony formation in vitro
To determine the mechanism by which MHC class I restricted CD8 T cells kill KC, we assessed whether T cell lines could alter the ability of freshly isolated KC with colony forming potential to form colonies in vitro (Fig 2) . Primary cultures of KC pulsed with the minimal CTL epitope peptide of the E7 protein of HPV16 (RAHYNIVTF), or expressing E7 as a transgene, were cultured with RAHYNIVTF-specific CD8 + CTL lines, or, as a control, with an allospecific CTL line. Allospecific CTL effectively killed EL4 and C57 KC targets, and inhibited colony formation of C57 KC (Fig 2 a) . Similarly E7 peptide-specific CTL exclusively killed peptide-pulsed EL4 cells, and inhibited colony formation of peptide pulsed and K14-E7 KC (Fig 2 b) . Killing of peptide pulsed EL4 cells and inhibition of KC colony formation by E7 peptide specific CTL lines was then compared to inhibition with E7 specific CTL lines generated from C57 animals singly deficient in perforin, or Fas-L.
Fas-L -/-CTL killed EL4 cells and inhibited KC colony formation as effectively as competent CTL. Perforin -/-CTL were impaired in their ability to kill EL4 cells (Fig 2c) , but neither perforin-/-CTL (Fig 2c) (Fig 3 b) , and was also observed at similar frequency on animals receiving E7TCR spleen cells deficient in Fas-L or perforin (Fig 3 a) . Adoptive transfer of E7TCR spleen cells or E7TCR spleen cells deficient in either Fas-L or perforin to graft recipients, without concurrent E7 immunisation, or immunisation of graft recipients without concurrent cell transfer, did not induce graft rejection (Fig 3 a) . Taken together, these data indicate that expression of the cytotoxic effector molecules Fas-L and perforin by antigen specific CD8 + T cells, are not necessary for rejection of skin grafts expressing antigen in KC, replicating in vivo the findings for elimination of KC clonogenic potential by antigen specific T cell lines in vitro.
Interferon-γ induces apoptosis of KC
As perforin mediated lysis was not necessary for elimination of KC by CD8 T cells in vitro or of skin grafts in vivo, we examined whether a soluble factor produced by activated CD8 T cells might mediate impaired KC colony formation potential (Fig 4) . KC were exposed in vitro to supernatants from T cells co-cultured with peptide pulsed, irradiated splenocytes or, as a control, T cells stimulated with irradiated splenocytes without added peptide. Only supernatants from T cells co-cultured with splenocytes expressing cognate antigen could inhibit colony formation (Fig 4 a) . We hypothesised that IFN-γ, which is known to affect KC proliferation and differentiation, might be responsible for the observed inhibition of colony formation. Addition of recombinant IFN-γ inhibited KC colony formation in dose dependent fashion, with peak inhibition observed with exposure of KC to 100ng IFN-γ/mL (Fig 4 b) . IFN-γ mediated colony inhibition could largely be reversed by addition of the pan-caspase inhibitor zVAD-fmk but not by addition of a control analogue zFA ( Figure 4e ). T cell/splenocyte conditioned supernatants typically contained 6-7 µg/mL IFN-γ as assayed by ELISA, and were expected to contain other cytokines. To determine whether IFN-γ was the primary cytokine responsible for inhibiting colony formation, neutralising antibody to IFN-γ or TNF-a was added to plated KC exposed to T cell conditioned supernatant. Addition of anti-IFN-γ reduced maximal colony inhibition by the T cell conditioned supernatant in a dose dependent manner, whereas addition of control rat IgG or anti-TNF-a had no effect on colony inhibition induced by the T cell conditioned supernatant (Fig 4 c and d ). From these data we concluded that IFN-γ is the major soluble factor responsible for inhibition of colony formation by CTL conditioned supernatant.
Interferon-γ from CTLs is necessary and sufficient to inhibit keratinocyte colony formation in vitro
Taken together, these data show that exogenous IFN-γ at sufficient concentration inhibits KC colony formation. To determine whether effector cell derived IFN-γ is necessary for inhibition of KC colony formation by antigen activated CTL, IFN-γ -/-CTLs and KC from interferon-γ receptor subunit-1 (IFN-γR1 -/-) donors were used in the colony inhibition assay (Fig 5) . Killing of peptide pulsed EL4 cells and inhibition of KC colony formation by IFN-γ replete or deficient E7 specific CTL lines was compared. IFN-γ -/-CTL were impaired in their ability to inhibit KC colony formation but not in their ability to kill EL4 cells (Fig 5 a and b) . Finally, CTL conditioned supernatant was added to C57 or IFN-γR1 -/-KC. Colony formation from KC with intact signalling through their IFN-γR1 was inhibited by over 70% while colony formation by IFN-γR1 -/-KCs was not impaired by the same supernatants (Fig 5 c) . Similarly, colony formation from C57 KC pulsed with E7
peptide, and exposed to E7-specific T cells, was significantly inhibited (75%), while colony formation by KC not exposed to peptide and by peptide pulsed IFN-γR1 -/-KC was not affected by co-culture with E7-peptide specific CTLs (Fig 5 d ). These data demonstrate that signalling through IFN-γR1 is necessary for both T cell mediated and CTL conditioned supernatant mediated inhibition of KC colony formation in vitro.
Discussion
This study demonstrates that elimination of epithelium expressing non-self antigen only in keratinocytes requires CD8 T cells but does not require perforin, generally regarded as a sufficient effector mechanism for killing cultured cell lines in vitro and tumours in vivo. It shows further that elimination of KC with clonogenic potential concurrently expressing non-self antigens requires IFN-γ signalling to KC, and can be achieved by a sufficient concentration of IFN-γ in vitro.
Prior studies of T cell effector function in skin have focussed on rejection of grafts presenting major or minor histocompatibility antigens (Mason, 1988 (Takaku, 1987) . Whether these empiric interventions work through the proposed mechanism requires further study in animal models of these diseases. Gender-matched mice at 6-12 weeks of age were used as effector cell donors and skin graft donors and recipients, and were maintained under conventional conditions in specific pathogen free holding rooms in the Princess Alexandra Hospital Biological
Materials and Methods
Animals
Resources Facility. Protocols were approved by the institutional animal ethics committee.
Skin graft transplantation
Whole-thickness skin was grafted as previously described (Matsumoto et al., 2004) .
Grafts were assessed as technically successful if adherent and vascularised on day 8.
Individual grafts were considered rejected when no viable epidermis was evident.
Grafts were observed at least twice weekly for the duration of experiments and classified as showing no evidence of rejection if grafts were intact at day 100.
Combined active/passive immunotherapy for skin graft rejection
Combined active/passive immunotherapy was administered as previously described (Matsumoto et al., 2004) . Briefly, 5.0 x10 6 nucleated spleen cells from TCR transgenic mice or in vitro cultured CTLs were transferred to skin graft recipients on the day of grafting. Where indicated, mice were immunised subcutaneously at the tail base with OVA protein (50 µg/ mouse; Sigma Aldrich, St Louis, MO) or a hexa-histidine HPV16-E7 fusion protein (50 µg/ mouse), prepared in E. coli as previously described (Fernando et al., 1999) . Protein antigens were mixed with 10 µg QuilA (Iscotec AB, Lulea, Sweden)
prior to injection.
Generation of cytotoxic T lymphocyte lines
HPV16-E7 peptide specific CTL lines were prepared as previously described except that spleens were collected 7 days post immunisation rather than 3 weeks (Leggatt et al., 2002) . Cells were used at day 7 to 10 post stimulation. Allo-antigen specific CTLs were induced in BALB/c mice by a single subcutaneous immunisation with 2x10 7 irradiated C57 spleen cells. Donor spleens were collected after 7-10 days and cultured as described above except the allogeneic stimulator cells were irradiated in the absence of exogenous peptide. Anti-HA (influenza) peptide specific CTLs were generated exactly as described (Shanker et al., 2009 ).
Cell-free CTL supernatant was collected from perforin deficient CTLs which had been stimulated with antigen (E7-peptide pulsed, irradiated syngeneic splenocytes) 7 days previously. The supernatant was clarified by centrifugation at 3000 rpm for 10 min at then supplemented into the test wells with total volume maintained at 2 mL per well.
Control supernatant was collected from parallel cultures of perforin deficient CTLs expanded as above except peptide was omitted from the irradiated stimulator cells.
Cytotoxicity assay
51 Chromium release cytotoxicity assays with cultured CTL lines and conventional or KC targets were undertaken, and per cent specific lysis was calculated, as described previously (Leggatt et al., 2002) .
Keratinocyte Colony Inhibition Assay
Primary murine epithelial keratinocytes (KC) were isolated as previously described (Leggatt et al., 2002) , and 15-20,000 KC were added to each well of a 6-well tissue culture plate previously coated with rat tail collagen. Plates were then incubated for 3 days to allow adherence and colony formation to commence. Where indicated rm-IFN-γ (BD-Pharmingen, batch specific activity 1.1x10 8 U/mg), the pan-caspase inhibitor zVADfmk (Promega, Madison, WI) or control analogue zFA-fmk (ICN Pharmaceuticals Inc., Aurora, OH) was added into the culture media from day 4 to day 7. Bovine serum albumin (Sigma Aldrich) was used as a control for non-specific effects of protein addition. Soluble E7-peptide was added where indicated on assay day 3. After 24 hours, free peptide was removed by gentle washing prior to addition of CTL at different effector to target ratios (E:T). The assays were typically incubated for a further 3 days at 37C. Additional manipulations included blockade of IFN-γ (biotinylated, clone R4-6A2, BD Pharmingen), FasL (clone MFL4, BD Pharmingen), or TNF-a (clone G281-2626, BD Pharmingen) with purified, neutralising monoclonal antibodies which were added to wells daily. Affinity purified rat IgG1 (eBioscience, San Diego, CA) was used as a control treatment.
When distinct colonies were visible in "no treatment" wells, assays were terminated and 
Statistics
Specific lysis and colony inhibition data are expressed as mean ± SD. The statistical significance of differences was determined by 2-tailed, unpaired t-test using GraphPad
Prism (version 4.0) software. Kaplan-Meier plots were used to analyse skin graft survival, and a log rank test was used to examine the statistical significance of differences in the survival curves. Differences with P<0.05 were considered significant. 
